Ebola Outbreak Escalates in DRC Clinic Attack Raises Regional Health Security Concerns Salesforce Earnings Beat Expectations Yet Stock Slides What Investors Should Know George Soros Fund Takes Stake in Talkspace Telehealth Growth Potential Lyft Identified Among Potential Value Opportunities in Sub15 Stock Segment Delivery Hero Confirms Takeover Offer from Uber Potential Shift in Food Delivery Landscape Charter Communications Announces Enhanced Buyout Agreement for Liberty Broadband CPSS Q4 2025 Earnings EPS Misses Consensus Amidst Challenging Auto Finance Environment SY Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Sentiment as Revenue Remains Under Wraps Essex Property Trust ESS Q1 2026 Earnings EPS Surges Past Estimates on Strong Operating Performance Under Armour UA Q1 2026 Earnings WiderThanExpected Loss Sends Mixed Signals Freedom Holding Corp FRHC Q1 2026 Earnings Solid EPS Reported Amid Quiet Disclosure Shares Slip OBK Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Curis Inc CRIS Rallies on High Volume Testing Key Resistance at 053 Constellation Brands STZ Gains Slightly as Stock Navigates Key Support Zone TFS Financial Corporation TFSL Holds Steady Near Resistance Potential for Breakout or Reversal Tamboran Resources TBN Gains Ground Testing Key Resistance Levels Amid Sector Optimism Traws Pharma TRAW Surges 6 Key Levels to Watch After Breakout Move Pokmon Card Market Surges Nostalgia Speculation and Celebrity Influence Drive MillionDollar Sales AppLovin Shares Surge Amid Positive Market Sentiment Coal India OFS Oversubscribed Government Exercises Greenshoe Option After Rs 19000 Crore Bids HALO Stocks Emerge as New Investment Theme Buying What AI Cant Replace SpaceX Files for IPO Under Ticker SPCX Potentially Making Elon Musk a Trillionaire Endurance Technologies IPO Opens to Raise Rs 1162 Crore ixigo Partners with Uber and redBus to Offer Integrated Cab and Bus Booking for Train Passengers BBAI Q1 2026 Earnings EPS Misses Estimates as Losses Widen Tectonic Therapeutic TECX Slides 174 as Biotech Sector Headwinds Persist